Jaguar Health, Inc. Research And Development Expense

Quick Answer

Jaguar Health, Inc. reported Research And Development Expense of $16.54 million for the year ending 2024.

  • Jaguar Health, Inc. showed a decrease of -11.0% in Research And Development Expense from 2023 to 2024.
  • This data is from Jaguar Health, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
  • XBRL data for this metric is available from 2014 to 2024 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2014: $1.46 million | Q2 2014: $691.2 thousand | Q3 2014: $1.13 million | Q1 2015: $1.42 million | Q2 2015: $1.75 million | Q3 2015: $1.24 million | Q1 2016: $1.75 million | Q2 2016: $1.95 million | Q3 2016: $1.97 million | Q1 2017: $1.26 million | Q2 2017: $926.8 thousand | Q3 2017: $851.6 thousand | Q1 2018: $757.9 thousand | Q2 2018: $1.60 million | Q3 2018: $1.48 million | Q1 2019: $1.42 million | Q2 2019: $1.70 million | Q3 2019: $1.31 million | Q1 2020: $1.58 million | Q2 2020: $1.41 million | Q3 2020: $1.52 million | Q1 2021: $2.41 million | Q2 2021: $3.87 million | Q3 2021: $3.31 million | Q1 2022: $4.95 million | Q2 2022: $2.45 million | Q3 2022: $5.94 million | Q1 2023: $4.78 million | Q2 2023: $4.28 million | Q3 2023: $6.08 million | Q1 2024: $4.31 million | Q2 2024: $3.65 million | Q3 2024: $4.04 million | Q1 2025: $3.73 million | Q2 2025: $3.27 million | Q3 2025: $3.66 million.
  • Over the full 11 years of available data (2014 to 2024), Jaguar Health, Inc.'s Research And Development Expense has grown by 292.0%.
  • Historical annual values: Fiscal year 2024: $16.54 million | Fiscal year 2023: $18.60 million | Fiscal year 2022: $17.65 million | Fiscal year 2021: $15.08 million | Fiscal year 2020: $6.41 million | Fiscal year 2019: $5.82 million | Fiscal year 2018: $5.15 million | Fiscal year 2017: $4.27 million | Fiscal year 2016: $7.21 million | Fiscal year 2015: $6.48 million | Fiscal year 2014: $4.22 million.
  • Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: